263 related articles for article (PubMed ID: 15590668)
1. Sphingosine 1-phosphate analogs as receptor antagonists.
Davis MD; Clemens JJ; Macdonald TL; Lynch KR
J Biol Chem; 2005 Mar; 280(11):9833-41. PubMed ID: 15590668
[TBL] [Abstract][Full Text] [Related]
2. Synthetic sphingosine 1-phosphate receptor modulators--opportunities and potential pitfalls.
Bolli MH; Lescop C; Nayler O
Curr Top Med Chem; 2011; 11(6):726-57. PubMed ID: 21261590
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate chemical biology.
Lynch KR; Macdonald TL
Biochim Biophys Acta; 2008 Sep; 1781(9):508-12. PubMed ID: 18638568
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a sphingosine 1-phosphate receptor antagonist prodrug.
Kennedy PC; Zhu R; Huang T; Tomsig JL; Mathews TP; David M; Peyruchaud O; Macdonald TL; Lynch KR
J Pharmacol Exp Ther; 2011 Sep; 338(3):879-89. PubMed ID: 21632869
[TBL] [Abstract][Full Text] [Related]
5. Production and release of sphingosine 1-phosphate and the phosphorylated form of the immunomodulator FTY720.
Kihara A; Igarashi Y
Biochim Biophys Acta; 2008 Sep; 1781(9):496-502. PubMed ID: 18555808
[TBL] [Abstract][Full Text] [Related]
6. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
Gonzalez-Cabrera PJ; Hla T; Rosen H
J Biol Chem; 2007 Mar; 282(10):7254-64. PubMed ID: 17218309
[TBL] [Abstract][Full Text] [Related]
7. Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist.
Zhu R; Snyder AH; Kharel Y; Schaffter L; Sun Q; Kennedy PC; Lynch KR; Macdonald TL
J Med Chem; 2007 Dec; 50(25):6428-35. PubMed ID: 17994678
[TBL] [Abstract][Full Text] [Related]
8. Different response patterns of several ligands at the sphingosine-1-phosphate receptor subtype 3 (S1P(3)).
Jongsma M; van Unen J; van Loenen PB; Michel MC; Peters SL; Alewijnse AE
Br J Pharmacol; 2009 Apr; 156(8):1305-11. PubMed ID: 19309361
[TBL] [Abstract][Full Text] [Related]
9. Syntheses of sphingosine-1-phosphate analogues and their interaction with EDG/S1P receptors.
Lim HS; Park JJ; Ko K; Lee MH; Chung SK
Bioorg Med Chem Lett; 2004 May; 14(10):2499-503. PubMed ID: 15109640
[TBL] [Abstract][Full Text] [Related]
10. Individual variation of human S1P₁ coding sequence leads to heterogeneity in receptor function and drug interactions.
Obinata H; Gutkind S; Stitham J; Okuno T; Yokomizo T; Hwa J; Hla T
J Lipid Res; 2014 Dec; 55(12):2665-75. PubMed ID: 25293589
[TBL] [Abstract][Full Text] [Related]
11. Targeting sphingosine 1-phosphate (S1P) levels and S1P receptor functions for therapeutic immune interventions.
Gräler MH
Cell Physiol Biochem; 2010; 26(1):79-86. PubMed ID: 20502007
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of sphingosine 1-phosphate receptor agonist in human endothelial cells.
Butler J; Lana D; Round O; LaMontagne K
Prostaglandins Other Lipid Mediat; 2004 Jan; 73(1-2):29-45. PubMed ID: 15165029
[TBL] [Abstract][Full Text] [Related]
13. Immune cell regulation and cardiovascular effects of sphingosine 1-phosphate receptor agonists in rodents are mediated via distinct receptor subtypes.
Forrest M; Sun SY; Hajdu R; Bergstrom J; Card D; Doherty G; Hale J; Keohane C; Meyers C; Milligan J; Mills S; Nomura N; Rosen H; Rosenbach M; Shei GJ; Singer II; Tian M; West S; White V; Xie J; Proia RL; Mandala S
J Pharmacol Exp Ther; 2004 May; 309(2):758-68. PubMed ID: 14747617
[TBL] [Abstract][Full Text] [Related]
14. [Effects of sphingosine 1-phosphate on functions of T cell - review].
Huang WR; Wang LS; DA WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Aug; 13(4):718-22. PubMed ID: 16129068
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs.
Foss FW; Mathews TP; Kharel Y; Kennedy PC; Snyder AH; Davis MD; Lynch KR; Macdonald TL
Bioorg Med Chem; 2009 Aug; 17(16):6123-36. PubMed ID: 19632123
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of 4(5)-phenylimidazole-based analogues of sphingosine-1-phosphate and FTY720: discovery of potent S1P1 receptor agonists.
Clemens JJ; Davis MD; Lynch KR; Macdonald TL
Bioorg Med Chem Lett; 2005 Aug; 15(15):3568-72. PubMed ID: 15982878
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: Alternative signaling of Th17 cell development by sphingosine 1-phosphate.
Liao JJ; Huang MC; Goetzl EJ
J Immunol; 2007 May; 178(9):5425-8. PubMed ID: 17442922
[TBL] [Abstract][Full Text] [Related]
18. Migration of CD4 T cells and dendritic cells toward sphingosine 1-phosphate (S1P) is mediated by different receptor subtypes: S1P regulates the functions of murine mature dendritic cells via S1P receptor type 3.
Maeda Y; Matsuyuki H; Shimano K; Kataoka H; Sugahara K; Chiba K
J Immunol; 2007 Mar; 178(6):3437-46. PubMed ID: 17339438
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist.
Murakami A; Takasugi H; Ohnuma S; Koide Y; Sakurai A; Takeda S; Hasegawa T; Sasamori J; Konno T; Hayashi K; Watanabe Y; Mori K; Sato Y; Takahashi A; Mochizuki N; Takakura N
Mol Pharmacol; 2010 Apr; 77(4):704-13. PubMed ID: 20097776
[TBL] [Abstract][Full Text] [Related]
20. Sphingosine 1-phosphate restrains insulin-mediated keratinocyte proliferation via inhibition of Akt through the S1P2 receptor subtype.
Schüppel M; Kürschner U; Kleuser U; Schäfer-Korting M; Kleuser B
J Invest Dermatol; 2008 Jul; 128(7):1747-56. PubMed ID: 18219276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
